121 related articles for article (PubMed ID: 2805451)
21. The MRL-lpr/lpr mouse. A model for the study of rheumatoid arthritis.
Koopman WJ; Gay S
Scand J Rheumatol Suppl; 1988; 75():284-9. PubMed ID: 2467353
[TBL] [Abstract][Full Text] [Related]
22. Induction of various autoantibodies by mutant gene lpr in several strains of mice.
Izui S; Kelley VE; Masuda K; Yoshida H; Roths JB; Murphy ED
J Immunol; 1984 Jul; 133(1):227-33. PubMed ID: 6609979
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha.
Edwards CK; Zhou T; Zhang J; Baker TJ; De M; Long RE; Borcherding DR; Bowlin TL; Bluethmann H; Mountz JD
J Immunol; 1996 Aug; 157(4):1758-72. PubMed ID: 8759766
[TBL] [Abstract][Full Text] [Related]
24. Novel recombinant congenic mouse strain developing arthritis with enthesopathy.
Mori S; Tanda N; Ito MR; Oishi H; Tsubaki T; Komori H; Zhang MC; Ono M; Nishimura M; Nose M
Pathol Int; 2008 Jul; 58(7):407-14. PubMed ID: 18577108
[TBL] [Abstract][Full Text] [Related]
25. Lpr and MRL background gene involvement in the control of adjuvant enhanced arthritis in MRL-lpr mice.
Ratkay LG; Tait B; Tonzetich J; Waterfield JD
J Autoimmun; 1994 Oct; 7(5):561-73. PubMed ID: 7530961
[TBL] [Abstract][Full Text] [Related]
26. An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice.
Mihara M; Nakano T; Ohsugi Y
Clin Immunol Immunopathol; 1987 Dec; 45(3):366-74. PubMed ID: 3500002
[TBL] [Abstract][Full Text] [Related]
27. Genome analysis of collagen disease in MRL/lpr mice: polygenic inheritance resulting in the complex pathological manifestations.
Nose M; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Qu W; Mori S; Nakatsuru S
Int J Cardiol; 2000 Aug; 75 Suppl 1():S53-61; discussion S63. PubMed ID: 10980337
[TBL] [Abstract][Full Text] [Related]
28. [Functional analysis of an autoantigen reactive B cell clone derived from MRL/MP-lpr/lpr mice].
Kobayashi K; Hamano T; Kakishita E
Ryumachi; 1996 Dec; 36(6):844-55. PubMed ID: 9122824
[TBL] [Abstract][Full Text] [Related]
29. Serum immunoglobulin isotype profile of viable and non viable lymphoid cell chimaeras made with nude athymic lpr (lymphoproliferation) mouse recipients.
Tiberghien F; Jachez B; Montecino-Rodriguez E; Loor F
Autoimmunity; 1992; 11(3):151-8. PubMed ID: 1571477
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal rheumatoid factors from B6-lpr/lpr mice.
Warren RW; Sailstad DM; Pisetsky DS
Clin Exp Immunol; 1984 Dec; 58(3):731-6. PubMed ID: 6509801
[TBL] [Abstract][Full Text] [Related]
31. Selective pathogenicity of murine rheumatoid factors of the cryoprecipitable IgG3 subclass.
Berney T; Fulpius T; Shibata T; Reininger L; Van Snick J; Shan H; Weigert M; Marshak-Rothstein A; Izui S
Int Immunol; 1992 Jan; 4(1):93-9. PubMed ID: 1540551
[TBL] [Abstract][Full Text] [Related]
32. Serum amyloid P component and autoimmune parameters in the assessment of arthritis activity in MRL/lpr/lpr mice.
Rordorf-Adam C; Serban D; Pataki A; Grüninger M
Clin Exp Immunol; 1985 Sep; 61(3):509-16. PubMed ID: 3878240
[TBL] [Abstract][Full Text] [Related]
33. High level expression of the plasma cell antigen PC.1 on the T-cell subset expanding in MRL/MpJ-lpr/lpr mice: detection with a xenogeneic monoclonal antibody and alloantisera.
Dumont FJ; Habbersett RC; Coker LZ; Nichols EA; Treffinger JA
Cell Immunol; 1985 Dec; 96(2):327-37. PubMed ID: 2943419
[TBL] [Abstract][Full Text] [Related]
34. Vasculitis-susceptible genes in mice with a deficit in Fas-mediated apoptosis.
Nose M; Terada M; Nishihara M; Kamogawa J; Miyazaki T; Mori S; Nishimura M; Wang Y; Kamoto T; Hiai H
Int J Cardiol; 1998 Oct; 66 Suppl 1():S37-41; discussion S43. PubMed ID: 9951801
[TBL] [Abstract][Full Text] [Related]
35. Behavior and immune status of MRL mice in the postweaning period.
Sakić B; Szechtman H; Talangbayan H; Denburg S; Carbotte R; Denburg JA
Brain Behav Immun; 1994 Mar; 8(1):1-13. PubMed ID: 8003767
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of polyclonal B-cell activation in autoimmune B6-lpr/lpr mice.
Warren RW; Roths JB; Murphy ED; Pisetsky DS
Cell Immunol; 1984 Mar; 84(1):22-31. PubMed ID: 6199122
[TBL] [Abstract][Full Text] [Related]
37. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
Takahashi S; Nose M; Sasaki J; Yamamoto T; Kyogoku M
J Immunol; 1991 Jul; 147(2):515-9. PubMed ID: 2071894
[TBL] [Abstract][Full Text] [Related]
38. IgG3 cryoglobulins in autoimmune MRL-lpr/lpr mice: immunopathogenesis, therapeutic approaches and relevance to similar human diseases.
Izui S; Berney T; Shibata T; Fulpius T
Ann Rheum Dis; 1993 Mar; 52 Suppl 1(Suppl 1):S48-54. PubMed ID: 8481059
[TBL] [Abstract][Full Text] [Related]
39. Effect of etodolac, a new nonsteroidal anti-inflammatory drug, in MRL/lpr mice with articular lesions.
Yoshida-Suzuka H; Nakamura Y; Shibata Y; Kimura K
Agents Actions; 1991 Jul; 33(3-4):310-3. PubMed ID: 1835269
[TBL] [Abstract][Full Text] [Related]
40. Local IgA and IgM rheumatoid factor production in autoimmune MRL/lpr mice.
Jonsson R; Pitts A; Mestecky J; Koopman W
Autoimmunity; 1991; 10(1):7-14. PubMed ID: 1742425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
